71 related articles for article (PubMed ID: 29544711)
1. Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.
Mulick A; Walker J; Puntis S; Burke K; Symeonides S; Gourley C; Wanat M; Frost C; Sharpe M
Lancet Psychiatry; 2018 Apr; 5(4):321-326. PubMed ID: 29544711
[TBL] [Abstract][Full Text] [Related]
2. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer.
Walker J; Hansen CH; Martin P; Symeonides S; Gourley C; Wall L; Weller D; Murray G; Sharpe M;
Lancet Oncol; 2014 Sep; 15(10):1168-76. PubMed ID: 25175097
[TBL] [Abstract][Full Text] [Related]
3. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial.
Sharpe M; Walker J; Holm Hansen C; Martin P; Symeonides S; Gourley C; Wall L; Weller D; Murray G;
Lancet; 2014 Sep; 384(9948):1099-108. PubMed ID: 25175478
[TBL] [Abstract][Full Text] [Related]
4. Is improvement in comorbid major depression associated with longer survival in people with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials.
Mulick A; Walker J; Puntis S; Symeonides S; Gourley C; Burke K; Wanat M; Frost C; Sharpe M
J Psychosom Res; 2019 Jan; 116():106-112. PubMed ID: 30654986
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of integrated collaborative care for comorbid major depression in patients with cancer.
Duarte A; Walker J; Walker S; Richardson G; Holm Hansen C; Martin P; Murray G; Sculpher M; Sharpe M
J Psychosom Res; 2015 Dec; 79(6):465-70. PubMed ID: 26652589
[TBL] [Abstract][Full Text] [Related]
6. Management of depression for people with cancer (SMaRT oncology 1): a randomised trial.
Strong V; Waters R; Hibberd C; Murray G; Wall L; Walker J; McHugh G; Walker A; Sharpe M
Lancet; 2008 Jul; 372(9632):40-8. PubMed ID: 18603157
[TBL] [Abstract][Full Text] [Related]
7. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ;
Lancet Oncol; 2007 Jul; 8(7):603-12. PubMed ID: 17548243
[TBL] [Abstract][Full Text] [Related]
8. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
[TBL] [Abstract][Full Text] [Related]
9. The third symptom management research trial in oncology (SMaRT oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (depression care for people with lung cancer) to usual care, compared to usual care alone in patients with lung cancer.
Walker J; Cassidy J; Sharpe M;
Trials; 2009 Sep; 10():92. PubMed ID: 19793390
[TBL] [Abstract][Full Text] [Related]
10. Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials.
Ell K; Aranda MP; Xie B; Lee PJ; Chou CP
Am J Geriatr Psychiatry; 2010 Jun; 18(6):520-30. PubMed ID: 20220588
[TBL] [Abstract][Full Text] [Related]
11. Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial.
Duchesne GM; Woo HH; Bassett JK; Bowe SJ; D'Este C; Frydenberg M; King M; Ledwich L; Loblaw A; Malone S; Millar J; Milne R; Smith RG; Spry N; Stockler M; Syme RA; Tai KH; Turner S
Lancet Oncol; 2016 Jun; 17(6):727-737. PubMed ID: 27155740
[TBL] [Abstract][Full Text] [Related]
12. Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.
Beer TM; Hotte SJ; Saad F; Alekseev B; Matveev V; Fléchon A; Gravis G; Joly F; Chi KN; Malik Z; Blumenstein B; Stewart PS; Jacobs CA; Fizazi K
Lancet Oncol; 2017 Nov; 18(11):1532-1542. PubMed ID: 29033099
[TBL] [Abstract][Full Text] [Related]
13. Integrated management of major depression for people with cancer.
Walker J; Sharpe M
Int Rev Psychiatry; 2014 Dec; 26(6):657-68. PubMed ID: 25553783
[TBL] [Abstract][Full Text] [Related]
14. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews.
Chan CM; Wan Ahmad WA; Yusof MM; Ho GF; Krupat E
Psychooncology; 2015 Jun; 24(6):718-25. PubMed ID: 25345781
[TBL] [Abstract][Full Text] [Related]
15. The Healthy Activity Program (HAP), a lay counsellor-delivered brief psychological treatment for severe depression, in primary care in India: a randomised controlled trial.
Patel V; Weobong B; Weiss HA; Anand A; Bhat B; Katti B; Dimidjian S; Araya R; Hollon SD; King M; Vijayakumar L; Park AL; McDaid D; Wilson T; Velleman R; Kirkwood BR; Fairburn CG
Lancet; 2017 Jan; 389(10065):176-185. PubMed ID: 27988143
[TBL] [Abstract][Full Text] [Related]
16. Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
von Tresckow B; Kreissl S; Goergen H; Bröckelmann PJ; Pabst T; Fridrik M; Rummel M; Jung W; Thiemer J; Sasse S; Bürkle C; Baues C; Diehl V; Engert A; Borchmann P;
Lancet Haematol; 2018 Oct; 5(10):e462-e473. PubMed ID: 30290903
[TBL] [Abstract][Full Text] [Related]
17. Improving depression outcomes in older adults with comorbid medical illness.
Harpole LH; Williams JW; Olsen MK; Stechuchak KM; Oddone E; Callahan CM; Katon WJ; Lin EH; Grypma LM; Unützer J
Gen Hosp Psychiatry; 2005; 27(1):4-12. PubMed ID: 15694213
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF; Cho BC; Vanakesa T; De Pas T; Zielinski M; Kim MS; Jassem J; Yoshimura M; Dahabreh J; Nakayama H; Havel L; Kondo H; Mitsudomi T; Zarogoulidis K; Gladkov OA; Udud K; Tada H; Hoffman H; Bugge A; Taylor P; Gonzalez EE; Liao ML; He J; Pujol JL; Louahed J; Debois M; Brichard V; Debruyne C; Therasse P; Altorki N
Lancet Oncol; 2016 Jun; 17(6):822-835. PubMed ID: 27132212
[TBL] [Abstract][Full Text] [Related]
19. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
[TBL] [Abstract][Full Text] [Related]
20. Long-term cost-effectiveness of collaborative care (vs usual care) for people with depression and comorbid diabetes or cardiovascular disease: a Markov model informed by the COINCIDE randomised controlled trial.
Camacho EM; Ntais D; Coventry P; Bower P; Lovell K; Chew-Graham C; Baguley C; Gask L; Dickens C; Davies LM
BMJ Open; 2016 Oct; 6(10):e012514. PubMed ID: 27855101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
